Detailed Narrative
Navigating Regulatory Accounting Changes
The quarter was defined by the transition to the new 1-by-N accounting method mandated by the IRDAI. This change defers the recognition of premium and commissions for multi-year policies. Consequently, while like-for-like GWP for 9M FY25 grew a strong 30.2% to ₹5,011 crores, the reported GWP was lower at ₹4,683 crores, a 21.7% growth. Management repeatedly emphasized that investors should focus on the IFRS-based financials, which show a 9M PAT of ₹119.5 crores, as the truest reflection of the business's underlying economic value, in contrast to the IGAAP PAT of ₹7.4 crores.
Profitability and Expense Management
On a like-to-like basis, the combined ratio for the first nine months improved by 230 basis points to 100.9%. However, the company's Expense of Management (EOM) ratio stood at 39%, exceeding the regulatory cap. Management confirmed they have received formal dispensation from the regulator and are on an approved 'glide path' to meet the 36% EOM limit by the next financial year. The key levers for this reduction are expected to be operating leverage from technology investments and the growing, more profitable renewal book.
Strategic Initiatives and Market Position
Niva Bupa continued to gain ground, with its retail health market share increasing to 9.6% from 9.0% a year ago. A key strategic launch during the quarter was a tiered network product, offering customers a 15% premium discount for choosing a more restricted hospital network, a first step towards cost and experience control. Operationally, the company is driving efficiency through technology, with 28.6% of cashless claims now being auto-adjudicated without human intervention.
Distribution Network Expansion
The company continues to deepen its multi-channel distribution. In the quarter, it added over 9,000 agents, 11 partners in the bancassurance space, and 8 brokers. Management noted that while the 1-by-N accounting change caused some transition friction with channel partners regarding commission structures, the overall distribution mix remains well-diversified and robust.
Outlook on Hospital Negotiations and Tariffs
A significant forward-looking theme was the regulatory push for the insurance industry to establish a common network and standardized tariffs for negotiations with hospitals, similar to the PMJ program. Management views this as a 'potential game changer' for the industry. They believe this collective approach could effectively address medical inflation and bring much-needed cost predictability, with benefits ultimately passing to the consumer through more stable premiums.